Test Price
2,800 AED✅ Home Collection Available
SCN2A Gene Dravet Syndrome Genetic Test in Dubai, UAE | 2800 AED
Executive Summary & Core Metrics
✅ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
🚑 Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
🩺 Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
💳 Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This SCN2A Genetic Test utilizes next‑generation sequencing (NGS) to detect pathogenic variants in the SCN2A gene, providing a definitive molecular diagnosis for Dravet syndrome and guiding tailored neurological management.
| Feature | Our Test (DNA Labs UAE) | Closest Alternative (Conventional Sanger Sequencing) |
|---|---|---|
| Methodology | NGS – full gene coverage with copy number variant detection | Sanger sequencing – limited to targeted exons |
| Diagnostic Sensitivity | 99.9% | ~85% for point mutations only |
| Turnaround Time | 3 – 4 Weeks | 5 – 7 Weeks |
| Sample Requirements | Whole blood, extracted DNA, or one drop of blood on an FTA card | Whole blood only |
| Clinical Support | Post‑test tele‑guidance included | Not provided |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I recognize the critical role of precise molecular diagnosis in Dravet syndrome. This NGS test offers comprehensive coverage of the SCN2A gene, but results should always be interpreted alongside a detailed clinical evaluation and family history. Our multidisciplinary team provides thorough pre-test counseling and post-test guidance to support patients and families throughout their journey.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠️ Medication Warning
Do not discontinue prescribed antiepileptic medication without consulting your doctor. Abrupt withdrawal can trigger severe seizures.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Current febrile illness, active bleeding disorder, or inability to provide informed consent.
- Exclusion: Patients younger than 72 hours old (heel‑stick sampling not applicable for this test).
- Red Flag: Any seizure lasting longer than 5 minutes or repeating without full recovery — call 998 immediately.
- Red Flag: Sudden deterioration of consciousness, difficulty breathing, or bluish skin after a seizure.
Patient FAQ & Clinical Guidance
1. What does the SCN2A gene test detect?
This test identifies pathogenic mutations in the SCN2A gene that cause Dravet syndrome, enabling precision diagnosis. It covers single nucleotide variants, small insertions/deletions, and large copy number changes, providing a comprehensive molecular profile that guides antiepileptic drug selection and prognosis.
2. Who should consider this test?
Individuals with early‑onset epileptic seizures, developmental delays, or a family history of Dravet syndrome should consider testing. The test is indicated for infants and children presenting with prolonged febrile seizures, myoclonic jerks, or atypical absence seizures. It is also valuable for asymptomatic siblings when a familial mutation is known.
3. How do I prepare for the test?
No fasting or medication adjustments are required, but a pre‑genetic counseling session is mandatory to review family history. A certified genetic counsellor will draw a detailed pedigree chart of affected family members, assess inheritance patterns, and explain the implications of possible results. Blood collection can be done at home through our VIP mobile phlebotomy service at your convenience.
UAE Regulatory & Data Privacy Adherence
Data Protection: DNA Labs UAE strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted and accessible only to authorized medical staff.
Clinical Safety: The test adheres to the standards outlined in Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring patient consent and clinical safety are prioritized throughout the testing process.
Clinical & Logistical Metadata
| Test Name | SCN2A Gene Dravet Syndrome Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Whole blood, extracted DNA, or FTA card |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | G40.89 |
| LOINC Code | 81378-8 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians